Public Board papers 31.03.22

5. Well-Led

5.1 - Finance (Executive Summary)

This report outlines the consolidated financial performance of The Christie NHS Foundation Trust and its wholly owned subsidiary The Christie Pharmacy Ltd.

I&E • The Trust position as at month 11 is a year to date surplus of £1.076m (in month deficit of £653k against an agreed nil balance control total for the year which reflects the new GM financial arrangements in place for M1-12). • The month 11 EBITDA position is a surplus of £41.961m • The month 11 I&E surplus is £17.411m, prior to adjusting for donated depreciation, charitably funded capital donations, donated grant income and impairments. • Month 1- 11 CIP has been achieved through underspends on pay within divisions. Balance sheet / liquidity • The cash balance is £167,227k. • Debtor days increased from 8 to 13 days from the previous month. • Capital expenditure is 91% of the NHSI plan & 95.1% of the reduced £2.5m NHSI plan. Other • The TCPC position for the 2 months period ending 28 February 2022 reports a distributable profit of £1.7m. The Trust share of the 2022 TCPC distributable profit will be reflected in the Trust financial performance based on the contractual arrangements of the TCPC . • 30 day PSPP is at 97% for trade and 91% NHS.

Exchequer Cash Balances 2021-22

£175,000

£150,000

£125,000

£100,000

Cash balances

£'000

£75,000

£50,000

£25,000

Apr-21 May-21 Jun-21 Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21 Jan-22 Feb-22 Mar-22

54

34